How to Buy BioNTech (BNTX) Stock

Want to jump straight to the best? Most of our users prefer Interactive Brokers for stock trading.

BioNTech (NASDAQ:BNTX)

159.800

0 [0%]
121.32 – 464
243.02M
2.78K/1.60M
38.83B
243.02M
2.111/1.32%
0.000
0.00K

Shares of German pharmaceutical company BioNTech SE (NASDAQ: BNTX) have been on a steady price climb since the company’s partner Pfizer (NYSE: PFE) announced that its trial vaccination for the COVID-19 virus was showing efficacy rates of over 90%. BioNTech co-Founder and Chief Executive Ugur Sahin has shown confidence in the trial vaccination, telling the BBC that he believed the vaccination has the potential to bring about a “normal winter” by next year.

Though BioNTech and Pfizer are unlikely to announce that their vaccines are available at your local pharmacy anytime soon, BioNTech’s rising stock prices may provide an opportunity for investors. If you’re considering investing in BioNTech stock but aren’t sure where to begin your research, start with our complete guide to brokers, investment possibilities and more. 

How to Buy BioNTech (NASDAQ: BNTX) Stock

No matter if you’re searching for stocks under $20 to add to your portfolio or more expensive, longer-term investments like BioNTech stock, you’ll follow the same basic process when you invest. Here’s how to get started. 

  1. Pick a Brokerage

    As a retail investor, you cannot buy and sell shares of stock directly on an exchange like the New York Stock Exchange or the NASDAQ. Instead, you’ll make your investments by working through a broker, which is a financial company licensed to buy and sell shares of stock on your behalf. You’ll provide instructions to your broker through the broker’s online platform, and the broker will then execute the order on your behalf.

  2. Decide How Many Shares You Want

    After opening your brokerage account, you’ll need to add funds to trade with. Most brokers allow you to do this by linking your bank account and initiating a direct transfer through your brokerage platform. If you’ve just opened your brokerage account, you might need to verify your bank account before you can start a fund transfer.

    Take a look at the current price of BioNTech stock and decide how much money you can afford to invest. Calculate how many shares you can purchase with your investment funds using the current market price of a single share of stock. Remember that there is no guarantee that BioNTech’s stock will increase in value — so never invest more money than you can afford to lose. 

  3. Choose Your Order Type

    After deciding how many shares of stock you want to buy, place an order through your broker’s platform. An order is a set of instructions that tells your broker which stock you want to buy and the price that you want to buy it at. The best brokers offer you a wide range of order types, so understanding the difference between each type is important. The order that you choose can affect how much you pay for each share of stock. 

    Bid: The bid price is the highest price that a buyer is currently willing to pay for 1 share of any given stock. Though a bid price isn’t a type of order, tracking how the bid price is changing can help you buy in at the most advantageous time.   
    Ask: The ask price is the lowest price that an investor is willing to sell a single share of any given stock for. Like the bid price, the ask price can help you decide when is the best time to place your order. 
    Spread: The spread is the difference between the bid price and the ask price. Be sure to pay special attention to the spread if you’re buying or selling a less liquid asset with a lower daily volume. Some stocks under $10 have high bid-ask spreads, which can cause you to pay more for a single share of stock than you anticipated or sell it off for less. 
    Limit Order: A limit order is a type of order that tells your broker that you want to purchase stocks at or below a certain price point. For example, imagine that shares of BioNTech stock are currently trading at $100 per share. You might place a limit order for 100 shares of BioNTech at $100 per share.
    Your broker will execute the order only if it’s possible to purchase each share for $100 per share or less. If the price of BioNTech stock rises above $100 per share, the broker won’t fill the order. Limit orders are less likely to be filled when compared to market orders but they offer you the benefit of knowing exactly how much money you’ll pay for each share you invest in. 
    Market Order: A market order is an order type that tells your broker that you want to purchase a select number of shares of a stock at the current rate — no matter what that price is. When your broker receives a market order, they will fill the order as soon as possible at the current market price.
    Market orders are more likely to be filled than limit orders. However, you could pay more for each share than the price you see on your brokerage account when you place the order because market prices are constantly fluctuating. 
    Stop-Loss Order: A stop-loss order is a type of sell order that prevents you from excessive loss. Stop-loss orders execute if the price of a stock falls to a certain level.

    For example, imagine that you purchase 10 shares of stock for $100 per share. You could set a stop-loss order for $95, which means that your broker would automatically sell your shares if the price of the stock falls to $95. This prevents you from losing more than 5% of your initial investment. 
    Stop-Limit Order

    A stop-limit order combines characteristics from both a limit order and a stop order. This type of order gives you more control over the conditions you’d like to place an order under.

    For example, imagine that shares of BioNTech are currently trading at $100 per share and showing upward momentum. You might place a stop-limit order with a limit price of $115 and a stop price of $105. In this example, if the price of BioNTech hits $105 per share, the order turns into a limit order, and your broker will execute the order so long as shares can be bought before the limit price of $115 is reached. 

  4. Execute Your Trade

    After you’ve placed your order, you can sit back and relax. Your broker will execute the order as you’ve directed. If you’ve placed an order that cannot be filled by the end of the day, your broker will usually cancel the order.  

Best Online Stock Brokers

get started securely through Webull’s website
Best For
Intermediate Traders and Investors
N/A
1 Minute Review

Webull, founded in 2017, is a mobile app-based brokerage that features commission-free stock and exchange-traded fund (ETF) trading. It’s regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).

Webull offers active traders technical indicators, economic calendars, ratings from research agencies, margin trading and short-selling. Webull’s trading platform is designed for intermediate and experienced traders, although beginning traders can also benefit.

Webull is widely considered one of the best Robinhood alternatives.

Best For
  • Active traders
  • Intermediate traders
  • Advanced traders
Pros
  • No account maintenance fees or software platform fees
  • No charges to open and maintain an account
  • Intuitive trading platform with technical and fundamental analysis tools
Cons
  • Does not support trading in mutual funds, bonds or OTC stocks
get started securely through Moomoo’s website
Best For
Active Traders
N/A
1 Minute Review

Moomoo is a commission-free mobile trading app available on Apple, Google and Windows devices. A subsidiary of Futu Holdings Ltd., it’s backed by venture capital affiliates of Matrix, Sequoia, and Tencent (NASDAQ: FUTU). Securities offered by Futu Inc., regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).

Moomoo is another great alternative for Robinhood. This is an outstanding trading platform if you want to dive deep into smart trading. It offers impressive trading tools and opportunities for both new and advanced traders, including advanced charting, pre and post-market trading, international trading, research and analysis tools, and most popular of all, free Level 2 quotes.

Get started right away by downloading Moomoo to your phone, tablet or another mobile device.

Best For
  • Cost-conscious traders
  • Active and Advanced traders
Pros
  • Over 8,000 different stocks that can be sold short
  • Access trading and quotes in pre-market (4 a.m. to 9:30 a.m. ET) and post-market hours (4 p.m. to 8 p.m. ET)
  • No minimum deposit to open an account.
Cons
  • No chat support
Get started securely through Axos Invest’s website
Best For
Sign Up Bonus
N/A
1 Minute Review

It seems like new digital investment management platforms are sprouting up left and right, and for good reason — there’s a great need for easy, straightforward investment management that doesn’t cost an arm and a leg in fees or to get started. If you’re new to investing or an old hat who wants to make the switch to a virtual manager, deciding which features you need can be confusing if not overwhelming.

If you want a no-frills financial management platform, Axos Invest (formerly WiseBanyan) takes a traditional but sophisticated approach to automated online investing.

Best For
  • Traditional investors trying out an automated investor for the first time
  • New investors that want to take a hands-off approach to portfolio management
Pros
  • Straightforward automated investing
  • Relatively low account minimum and automated investing fee
  • A solid roster of available investment account types
Cons
  • Not a stand-out from other services if you’re someone who likes all the bells and whistles with your digital financial platform
  • No direct relationship with a human financial advisor
get started securely through Interactive Broker’s website
Best For
GlobalAnalyst Product
N/A
1 Minute Review

This latest groundbreaking technology is IBKR GlobalAnalyst, a new trading tool that helps investors compare the rate of PEG or price-earnings growth valuations and provide more immediate and comprehensive financial metrics of stocks, globally.

Recognizing that stock selection can be challenging for investors to compare the valuations of domestic and international stocks, Interactive Brokers created GlobalAnalyst to offer investors a simple, yet powerful tool to easily evaluate investment opportunities around the world.

Using GlobalAnalyst, investors can search for stocks by region, country, industry, market capitalization and currency to uncover undervalued stocks worldwide. The resulting table displays the current market and financial metrics, including the PEG Ratio. The PEG Ratio is the PE ratio divided by the three-year compound earnings growth rate, and smaller PEG Ratios typically indicate undervalued companies.

Best For
  • Price earnings growth valuations
Pros
  • Easily evaluate investment opportunities
Cons
get started securely through eToro’s website
Disclosure: eToro USA LLC; Investments are subject to market risk, including the possible loss of principal.
Best For
Copy Trading
N/A
1 Minute Review

eToro is a broker that offers access to over 25 of the world’s most popular cryptocurrencies, forex and over 1600 stocks. They have a few unique education and useability tools. Traders can begin buying and selling in as little as 10 minutes.

eToro’s unique CopyTrader feature allows new investors to “copy” the buy and sell orders of professional investors, while the company’s eToro Club feature provides investors with a range of additional education tools and resources. 

Best For
  • Traders looking for an easy-to-use platform
  • Traders who want to practice their trades using a virtual account before entering the market
Pros
  • Simple platform that is easy to master
  • CopyTrader feature that allows new traders to copy the same strategies used by professionals
  • Virtual dummy account that gives you $100,000 to practice trades
Cons
  • High non-trading fees

BioNTech Stock History

Headquartered in Mainz, Germany, BioNTech is a pharmaceutical company with a history dating back to 2008. Prior to its partnership with Pfizer, the company specialized in creating individualized cancer immunotherapies, vaccinations and protein replacement therapies. BioNTech’s vaccinations rely on the manipulation of messenger RNA.

BioNTech Stock History

BioNTech’s stock has seen steady upward momentum, even through the COVID-19 pandemic.

BioNTech’s stock has seen steady upward momentum since its initial public offering in October 2019. Debuting at $14.24 per share, BioNTech’s stock price peaked at $112.76 per share on November 10, 2020, when news broke that that company’s vaccination candidate for the novel COVID-19 virus was showing high efficacy rates of over 90% in clinical trials. Since this peak, the share price of BioNTech’s stock has fallen at the time of writing.   

Pros to Buying BioNTech Stock

Investors are keeping their eyes on BioNTech thanks to the company’s partnership with Pfizer in creating a COVID-19 vaccination candidate. Phase 3 trials have supported evidence that the vaccine is effective at showing a “dramatic reduction” in the transmission of COVID-19 with efficacy rates of over 90%. This is well above the threshold of 50% efficacy set by the Food and Drug Administration (FDA) for vaccination candidates.

The company will soon begin seeking approval for emergency applications with the FDA. If approved, BioNTech and Pfizer plan to distribute about 1.3 billion doses of the vaccination by the year 2021. This development could potentially cause BioNTech’s stock price to skyrocket, as demand for a safe COVID-19 vaccination dominates the medical field. 

Cons to Buying BioNTech Stock

Even if the emergency application is approved by the FDA, there is no guarantee that vaccine production will increase the price of BioNTech’s stock. BioNTech has created the vaccine candidate in cooperation with Pfizer, which has already stated that it agreed to supply the U.S. government with the vaccine at $19.50 per dose when approved. It’s possible that this price may be pushed even lower, as public demand for affordable vaccinations mounts.

BioNTech and Pfizer are also far from the only companies developing vaccination candidates to combat the COVID-19 pandemic. American biotech company Moderna recently released data supporting a 94% efficacy rate for its vaccine candidate. Moderna’s vaccination candidate can also be stored at a temperature of 36 to 46 degrees F, while BioNTech’s candidate must be stored at a temperature of -94 degrees F in a specialized medical freezer to remain effective. This temperature requirement may drastically reduce the company’s vaccination appeal to lawmakers and health experts, especially in countries outside of the U.S. due to logistics challenges. 

Adding BioNTech to Your Portfolio

No matter if you decide to invest in BioNTech or penny stocks under $5, doing your due diligence is crucial to investing intelligently. Remember that the value of any stock is never guaranteed, and companies can see their stock fall in value at any time. Never invest more money than you can afford to lose, and be sure to always diversify your portfolio in order to protect your investments.